Media coverage
1Media coverage
Title FDA Approves Stiolto Respimat Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction Media name/outlet Pharmacy Choice Country United States Date 10/11/18 Persons Antonio R Anzueto
Press/Media: Press / Media
Media coverage
Title | FDA Approves Stiolto Respimat Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction |
---|---|
Media name/outlet | Pharmacy Choice |
Country | United States |
Date | 10/11/18 |
Persons | Antonio R Anzueto |